Induction of liver hypertrophy for extended liver surgery and partial liver transplantation: State of the art of parenchyma augmentation-assisted liver surgery


Creative Commons License

Muller P. C., Linecker M., KIRIMKER E. O., Oberkofler C. E., Clavien P., BALCI D., ...Daha Fazla

LANGENBECKS ARCHIVES OF SURGERY, cilt.406, ss.2201-2215, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 406
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1007/s00423-021-02148-2
  • Dergi Adı: LANGENBECKS ARCHIVES OF SURGERY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.2201-2215
  • Anahtar Kelimeler: Liver surgery, Liver augmentation, Portal vein embolization, Transarterial chemoembolization, Two-staged hepatectomy, Associating liver partition and portal vein ligation for staged hepatectomy
  • Ankara Üniversitesi Adresli: Evet

Özet

Background Liver surgery and transplantation currently represent the only curative treatment options for primary and secondary hepatic malignancies. Despite the ability of the liver to regenerate after tissue loss, 25-30% future liver remnant is considered the minimum requirement to prevent serious risk for post-hepatectomy liver failure. Purpose The aim of this review is to depict the various interventions for liver parenchyma augmentation-assisting surgery enabling extended liver resections. The article summarizes one- and two-stage procedures with a focus on hypertrophy- and corresponding resection rates. Conclusions To induce liver parenchymal augmentation prior to hepatectomy, most techniques rely on portal vein occlusion, but more recently inclusion of parenchymal splitting, hepatic vein occlusion, and partial liver transplantation has extended the technical armamentarium. Safely accomplishing major and ultimately total hepatectomy by these techniques requires integration into a meaningful oncological concept. The advent of highly effective chemotherapeutic regimen in the neo-adjuvant, interstage, and adjuvant setting has underlined an aggressive surgical approach in the given setting to convert formerly "palliative" disease into a curative and sometimes in a "chronic" disease.